GLP-1 Drugs Strain Employer Benefits | Hattiesburg News

GLP-1 drugs are revolutionizing weight loss and diabetes care—but at a steep price for employers. With healthcare costs projected to jump 9.2% by 2027, 14% of companies are cutting or planning to cut coverage for these meds. Meanwhile, two-thirds of employers report a surge in employee usage, fueling the financial pressure. As coverage drops from 72% to 60% in just one year, businesses scramble to balance affordability with employee wellness—forcing tough, creative choices. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9c1e0a265486c2b5